132 related articles for article (PubMed ID: 22357443)
21. Detection and identification of oxidized insulin-like growth factor-binding proteins and receptors in patients with colorectal carcinoma.
Nedić O; Robajac D; Šunderić M; Miljuš G; Đukanović B; Malenković V
Free Radic Biol Med; 2013 Dec; 65():1195-1200. PubMed ID: 24051179
[TBL] [Abstract][Full Text] [Related]
22. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
24. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
25. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
26. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
27. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.
Lin Y; Jiang T; Zhou K; Xu L; Chen B; Li G; Qiu X; Jiang T; Zhang W; Song SW
Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
[TBL] [Abstract][Full Text] [Related]
29. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer.
Baron-Hay S; Boyle F; Ferrier A; Scott C
Clin Cancer Res; 2004 Mar; 10(5):1796-806. PubMed ID: 15014034
[TBL] [Abstract][Full Text] [Related]
30. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
[TBL] [Abstract][Full Text] [Related]
32. Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer.
Mai D; Zheng Y; Guo H; Ding P; Bai R; Li M; Ye Y; Zhang J; Huang X; Liu D; Sui Q; Pan L; Su J; Deng J; Wu G; Li R; Deng S; Bai Y; Ligu Y; Tan W; Wu C; Wu T; Zheng J; Lin D
Theranostics; 2020; 10(19):8468-8478. PubMed ID: 32754257
[No Abstract] [Full Text] [Related]
33. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
[TBL] [Abstract][Full Text] [Related]
34. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
Feng X; Lin J; Xing S; Liu W; Zhang G
BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
[TBL] [Abstract][Full Text] [Related]
37. Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.
Matuschek C; Rudoy M; Peiper M; Gerber PA; Hoff NP; Buhren BA; Flehmig B; Budach W; Knoefel WT; Bojar H; Prisack HB; Steinbach G; Shukla V; Schwarz A; Kammers K; Erhardt A; Scherer A; Bölke E; Schauer M
Eur J Med Res; 2011 Oct; 16(10):451-6. PubMed ID: 22024424
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factors (IGF), IGF-binding proteins (IGFBP), and vascular endothelial growth factor (VEGF) in blood serum of patients with colorectal cancer.
Kushlinskii NE; Gershtein ES; Nikolaev AA; Delektorskaya VV; Korotkova EA; Dvorova EK; Kostyleva OI
Bull Exp Biol Med; 2014 Mar; 156(5):684-8. PubMed ID: 24770758
[TBL] [Abstract][Full Text] [Related]
39. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
40. A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom.
Young NJ; Metcalfe C; Gunnell D; Rowlands MA; Lane JA; Gilbert R; Avery KN; Davis M; Neal DE; Hamdy FC; Donovan J; Martin RM; Holly JM
Cancer Causes Control; 2012 Jun; 23(6):907-17. PubMed ID: 22527168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]